BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31956147)

  • 1. Percutaneous Simple Lead Traction Is a Feasible and Effective Method for Right Ventricular Lead Perforations.
    Mori H; Kato R; Ikeda Y; Tsutsui K; Hasegawa S; Tanaka S; Iwanaga S; Nakano S; Muramatsu T; Sumitomo N; Matsumoto K
    Int Heart J; 2020 Jan; 61(1):54-59. PubMed ID: 31956147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, management, and prevention of right ventricular perforation by pacemaker and implantable cardioverter defibrillator leads.
    Migliore F; Zorzi A; Bertaglia E; Leoni L; Siciliano M; De Lazzari M; Ignatiuk B; Veronese M; Verlato R; Tarantini G; Iliceto S; Corrado D
    Pacing Clin Electrophysiol; 2014 Dec; 37(12):1602-9. PubMed ID: 25131984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous lead extraction and repositioning: An effective and safe therapeutic strategy for early ventricular lead perforation with dislocation both inside and outside the pericardial sac following a cardiac device implantation.
    Archontakis S; Sideris K; Aggeli K; Gatzoulis K; Demosthenous M; Tolios P; Lozos V; Koumallos N; Limperiadis D; Tousoulis D; Kallikazaros I; Sideris S
    J Cardiovasc Electrophysiol; 2019 Mar; 30(3):299-307. PubMed ID: 30516299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transvenous revision of leads with cardiac perforation following device implantation-Safety, outcome, and complications.
    Döring M; Müssigbrodt A; Ebert M; Bode K; Lucas J; Dagres N; Hindricks G; Richter S
    Pacing Clin Electrophysiol; 2020 Nov; 43(11):1325-1332. PubMed ID: 32909622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pacing and implantable cardioverter defibrillator lead perforation as assessed by multiplanar reformatted ECG-gated cardiac computed tomography and clinical correlates.
    Pang BJ; Lui EH; Joshi SB; Tacey MA; Alison J; Seneviratne SK; Cameron JD; Mond HG
    Pacing Clin Electrophysiol; 2014 May; 37(5):537-45. PubMed ID: 24883448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The management of cardiac implantable electronic device lead perforations: a multicentre study.
    Rav Acha M; Rafael A; Keaney JJ; Elitzur Y; Danon A; Shauer A; Taha L; Shechter Y; Bogot NR; Luria D; Ilan M; Singh SM; Mela T; Weisz G; Glikson M; Medina A
    Europace; 2019 Jun; 21(6):937-943. PubMed ID: 31157389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of subacute and delayed right ventricular perforation with a pacing or an implantable cardioverter-defibrillator lead.
    Laborderie J; Barandon L; Ploux S; Deplagne A; Mokrani B; Reuter S; Le Gal F; Jais P; Haissaguerre M; Clementy J; Bordachar P
    Am J Cardiol; 2008 Nov; 102(10):1352-5. PubMed ID: 18993154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iatrogenic cardiac perforation due to pacemaker and defibrillator leads: a contemporary multicentre experience.
    Waddingham PH; Elliott J; Bates A; Bilham J; Muthumala A; Honarbakhsh S; Ullah W; Hunter RJ; Lambiase PD; Lane RE; Chow AWC
    Europace; 2022 Nov; 24(11):1824-1833. PubMed ID: 35894862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous management of lead-related cardiac perforation with limited use of computed tomography and cardiac surgery.
    Elbatran AI; Akhtar Z; Bajpai A; Leung LWM; Li A; Pearse S; Zuberi Z; Kaba R; Saba MM; Norman M; Grimster A; Gallagher MM; Sohal M
    Pacing Clin Electrophysiol; 2021 Apr; 44(4):614-624. PubMed ID: 33624296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclinical cardiac perforation by cardiac implantable electronic device leads detected by cardiac computed tomography.
    Lim YM; Uhm JS; Kim M; Kim IS; Jin MN; Yu HT; Kim TH; Lee HJ; Kim YJ; Joung B; Pak HN; Lee MH
    BMC Cardiovasc Disord; 2021 Jul; 21(1):346. PubMed ID: 34281506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-hospital complications after implantation of cardiac implantable electronic devices: Analysis of a national inpatient database in Japan.
    Shakya S; Matsui H; Fushimi K; Yasunaga H
    J Cardiol; 2017 Nov; 70(5):405-410. PubMed ID: 28434707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and characterization of asymptomatic pacemaker and ICD lead perforation on CT.
    Hirschl DA; Jain VR; Spindola-Franco H; Gross JN; Haramati LB
    Pacing Clin Electrophysiol; 2007 Jan; 30(1):28-32. PubMed ID: 17241311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of transvenous lead extraction in patients with lead perforation: A single-center experience.
    Zhou X; Ze F; Li D; Wang L; Guo J; Li X
    Clin Cardiol; 2020 Apr; 43(4):386-393. PubMed ID: 31904110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of lead revision for myocardial perforation after cardiac implantable electronic device placement.
    Huang XM; Fu HX; Zhong L; Osborn MJ; Asirvatham SJ; Sinak LJ; Cao J; Friedman PA; Cha YM
    J Cardiovasc Electrophysiol; 2014 Oct; 25(10):1119-24. PubMed ID: 24863054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased incidence of subacute lead perforation noted with one implantable cardioverter-defibrillator.
    Danik SB; Mansour M; Singh J; Reddy VY; Ellinor PT; Milan D; Heist EK; d'Avila A; Ruskin JN; Mela T
    Heart Rhythm; 2007 Apr; 4(4):439-42. PubMed ID: 17399630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and predictors of clinically relevant cardiac perforation associated with systematic implantation of active-fixation pacing and defibrillation leads: a single-centre experience with over 3800 implanted leads.
    Cano Ó; Andrés A; Alonso P; Osca J; Sancho-Tello MJ; Olagüe J; Martínez-Dolz L
    Europace; 2017 Jan; 19(1):96-102. PubMed ID: 26847075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility and Safety of Percutaneous Lead Revision for Subacute and Delayed Cardiac Device Lead Perforation.
    Issa ZF; Issa TZ
    JACC Clin Electrophysiol; 2021 Jan; 7(1):26-35. PubMed ID: 33478709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac perforation from implantable cardioverter-defibrillator lead placement: insights from the national cardiovascular data registry.
    Hsu JC; Varosy PD; Bao H; Dewland TA; Curtis JP; Marcus GM
    Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):582-90. PubMed ID: 24002030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subacute cardiac perforations associated with active fixation leads.
    Sterliński M; Przybylski A; Maciag A; Syska P; Pytkowski M; Lewandowski M; Kowalik I; Firek B; Kołsut P; Religa G; Kuśmierczyk M; Walczak F; Szwed H
    Europace; 2009 Feb; 11(2):206-12. PubMed ID: 19109359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymptomatic right ventricular perforation by an implantable cardioverter defibrillator lead detected by home monitoring system.
    Migliore F; Leoni L; Torregrossa G; Guglielmi C; Tarantini G; Buja G; Iliceto S; Corrado D
    J Electrocardiol; 2010; 43(6):673-5. PubMed ID: 20888001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.